erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
over years of research, scientists discovered that cgrp helps transmit pain signals in the brain.
.
.
.
.
. "the importance of our new method is that it allows for precise and automated measurement of the disease," bentley added in the study published in the journal radiology.
.
.
.
twins treated for genetic disorder in the womb
.
now the country may face a fine of millions of euros after its dereliction was referred to the european court of justice (ecj), the guardian reports.